NCT05680571View on ClinicalTrials.gov

Validation of Bulbicam for Parkinson- and Ataxia-patients

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

March 30, 2023

Conditions
Parkinson DiseaseAtaxia
Interventions
DEVICE

BulbiCam

BulbiCam is an non-invasive, multi-test device which combined eye tracking; pupil metric; video graphic dual device including the f10 tests under development and ready for validation

Trial Locations (1)

0372

Oslo University Hospital, Oslo

Sponsors

Lead Sponsor

Meddoc
All Listed Sponsors
lead

Meddoc

OTHER

NCT05680571 - Validation of Bulbicam for Parkinson- and Ataxia-patients | Biotech Hunter | Biotech Hunter